FDA Inspection
US Oncology, Inc. IRBUS Oncology, Inc. IRB – FDA Inspection, Jul 7, 2017
Record Details
This FDA Inspection record concerns US Oncology, Inc. IRB, with an inspection on July 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5bff253f-40c4-40c1-bbb0-bc302932b425
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1023482
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of US Oncology, Inc. IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2010 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| March 12, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for US Oncology, Inc. IRB
- FDA Inspection 674761 - 2010-07-28
- FDA Inspection 569265 - 2009-03-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.